215 related articles for article (PubMed ID: 16171463)
41. Acyl glucuronidation of fluoroquinolone antibiotics by the UDP-glucuronosyltransferase 1A subfamily in human liver microsomes.
Tachibana M; Tanaka M; Masubuchi Y; Horie T
Drug Metab Dispos; 2005 Jun; 33(6):803-11. PubMed ID: 15769885
[TBL] [Abstract][Full Text] [Related]
42. Molecular basis of perinatal changes in UDP-glucuronosyltransferase activity in maternal rat liver.
Luquita MG; Catania VA; Pozzi EJ; Veggi LM; Hoffman T; Pellegrino JM; Ikushiro Si ; Emi Y; Iyanagi T; Vore M; Mottino AD
J Pharmacol Exp Ther; 2001 Jul; 298(1):49-56. PubMed ID: 11408524
[TBL] [Abstract][Full Text] [Related]
43. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
[TBL] [Abstract][Full Text] [Related]
44. Gilbert and Crigler Najjar syndromes: an update of the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene mutation database.
Canu G; Minucci A; Zuppi C; Capoluongo E
Blood Cells Mol Dis; 2013 Apr; 50(4):273-80. PubMed ID: 23403257
[TBL] [Abstract][Full Text] [Related]
45. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation.
Hanioka N; Naito T; Narimatsu S
Chemosphere; 2008 Dec; 74(1):33-6. PubMed ID: 18990428
[TBL] [Abstract][Full Text] [Related]
46. Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine.
Sun H; Zhang T; Wu Z; Wu B
J Pharm Sci; 2015 Jan; 104(1):244-56. PubMed ID: 25393417
[TBL] [Abstract][Full Text] [Related]
47. Alteration of human UDP-glucuronosyltransferase UGT2B17 regio-specificity by a single amino acid substitution.
Dubois SG; Beaulieu M; Lévesque E; Hum DW; Bélanger A
J Mol Biol; 1999 May; 289(1):29-39. PubMed ID: 10339403
[TBL] [Abstract][Full Text] [Related]
48. Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance.
Miners JO; McKinnon RA; Mackenzie PI
Toxicology; 2002 Dec; 181-182():453-6. PubMed ID: 12505351
[TBL] [Abstract][Full Text] [Related]
49. Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II.
Aono S; Yamada Y; Keino H; Hanada N; Nakagawa T; Sasaoka Y; Yazawa T; Sato H; Koiwai O
Biochem Biophys Res Commun; 1993 Dec; 197(3):1239-44. PubMed ID: 8280139
[TBL] [Abstract][Full Text] [Related]
50. A new frame-shifting mutation of UGT1A1 gene causes type I Crigler-Najjar syndrome.
Wang J; Fang LJ; Li L; Wang JS; Chen C
Chin Med J (Engl); 2011 Dec; 124(23):4109-11. PubMed ID: 22340355
[TBL] [Abstract][Full Text] [Related]
51. Characterization of the UDP glucuronosyltransferase activity of human liver microsomes genotyped for the UGT1A1*28 polymorphism.
Zhang D; Zhang D; Cui D; Gambardella J; Ma L; Barros A; Wang L; Fu Y; Rahematpura S; Nielsen J; Donegan M; Zhang H; Humphreys WG
Drug Metab Dispos; 2007 Dec; 35(12):2270-80. PubMed ID: 17898154
[TBL] [Abstract][Full Text] [Related]
52. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of bergenin.
Song H; Wang J; Zhang R; Liu X; Yuan G; Wei C; Wang B; Guo R
Biomed Chromatogr; 2014 Mar; 28(3):348-53. PubMed ID: 23996546
[TBL] [Abstract][Full Text] [Related]
53. Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro.
Malfatti MA; Felton JS
Chem Res Toxicol; 2004 Aug; 17(8):1137-44. PubMed ID: 15310245
[TBL] [Abstract][Full Text] [Related]
54. Bilirubin UDP-glucuronosyltransferase 1A1 (UGT1A1) gene promoter polymorphisms and HPRT, glycophorin A, and micronuclei mutant frequencies in human blood.
Grant DJ; Hall IJ; Eastmond DA; Jones IM; Bell DA
Mutat Res; 2004 May; 560(1):1-10. PubMed ID: 15099818
[TBL] [Abstract][Full Text] [Related]
55. Evidence for regulation of UDP-glucuronosyltransferase (UGT) 1A1 protein expression and activity via DNA methylation in healthy human livers.
Yasar U; Greenblatt DJ; Guillemette C; Court MH
J Pharm Pharmacol; 2013 Jun; 65(6):874-83. PubMed ID: 23647681
[TBL] [Abstract][Full Text] [Related]
56. Severe hyperbilirubinaemia in a Chinese girl with type I Crigler-Najjar syndrome: first case ever reported in Mainland China.
Nong SH; Xie YM; Chan KW; Cheung PT
J Paediatr Child Health; 2005; 41(5-6):300-2. PubMed ID: 15953334
[TBL] [Abstract][Full Text] [Related]
57. Inter-isoform Hetero-dimerization of Human UDP-Glucuronosyltransferases (UGTs) 1A1, 1A9, and 2B7 and Impacts on Glucuronidation Activity.
Yuan LM; Gao ZZ; Sun HY; Qian SN; Xiao YS; Sun LL; Zeng S
Sci Rep; 2016 Nov; 6():34450. PubMed ID: 27857056
[TBL] [Abstract][Full Text] [Related]
58. Characterization of the uridine diphosphate-glucuronosyltransferase-catalyzing thyroid hormone glucuronidation in man.
Findlay KA; Kaptein E; Visser TJ; Burchell B
J Clin Endocrinol Metab; 2000 Aug; 85(8):2879-83. PubMed ID: 10946897
[TBL] [Abstract][Full Text] [Related]
59. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
Kaji H; Kume T
Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
[TBL] [Abstract][Full Text] [Related]
60. Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir.
Boyd MA; Srasuebkul P; Ruxrungtham K; Mackenzie PI; Uchaipichat V; Stek M; Lange JM; Phanuphak P; Cooper DA; Udomuksorn W; Miners JO
Pharmacogenet Genomics; 2006 May; 16(5):321-9. PubMed ID: 16609363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
